by Claire Westgate | Apr 8, 2026
NICE approves funding for Ripretinib for patients with GIST in England NICE has approved NHS funding for ripretinib for adults with advanced gastrointestinal stromal tumours (GIST) in England, marking an important step forward for patients whose cancer has progressed...
Recent Comments